Ep 184 Must Know Drug Interactions in Emergency Medicine
We miss potentially dangerous and even lethal drug interactions in EM more often than we realize. In this main episode EM Cases podcast with Dr. David Juurlink and Dr. Walter...
Anton Helman |
Welcome to our store!
New collections added on a weekly basis!
Now Accepting FSA & HSA cards
for all orders over $99.99 within the CONTINENTAL USA.
We miss potentially dangerous and even lethal drug interactions in EM more often than we realize. In this main episode EM Cases podcast with Dr. David Juurlink and Dr. Walter...
Anton Helman |
We miss potentially dangerous and even lethal drug interactions in EM more often than we realize. In this main episode EM Cases podcast with Dr. David Juurlink and Dr. Walter...
Anton Helman |
Background: Oral factor Xa inhibitors (FXi) have been associated with major and fatal bleeding events, including intracranial hemorrhage (ICH). In randomized controlled trials, both rivaroxaban and apixaban are associated with...
Marco Torres |
Anand Swaminathan on Lemierre's syndrome, Emily Austin on clonidine toxicity, Brit Long on myths of routine coagulation panel testing, Hans Rosenberg and Michael Ho on reversal of anticoagulation, Sheldon Cheskes on...
Anton Helman |
Anand Swaminathan on Lemierre's syndrome, Emily Austin on clonidine toxicity, Brit Long on myths of routine coagulation panel testing, Hans Rosenberg and Michael Ho on reversal of anticoagulation, Sheldon Cheskes on...
Anton Helman |
Background: The simplified PE Severity Index (sPESI) is one of several validated prognostic tools for acute pulmonary embolism (PE). The European Society of Cardiology recommended the use of the sPESI to...
Marco Torres |
The year 2016 was one of the most productive one in the entire 7 year history of EM Cases with a total of 29 podcast releases, the introduction of the...
Anton Helman |
The year 2016 was one of the most productive one in the entire 7 year history of EM Cases with a total of 29 podcast releases, the introduction of the...
Anton Helman |
In anticipation of Episode 88 and 89: DOACs Use, Misuse and Reversal with the president of Thrombosis Canada and world renowned thrombosis researcher Dr. Jim Douketis, internist and thrombosis expert...
Anton Helman |
In anticipation of Episode 88 and 89: DOACs Use, Misuse and Reversal with the president of Thrombosis Canada and world renowned thrombosis researcher Dr. Jim Douketis, internist and thrombosis expert...
Anton Helman |
Your cart
Visit our support center
Expert help & advice
Check your order status
Updates & tracking
Returns & exchanges
All you need to know
Everyday Low Prices
No need to wait for a "sale"
Choose options